Head-to-Head vaccine showdown: which COVID booster works better?
NCT ID NCT06065176
Summary
This study aimed to find out which of two updated COVID-19 booster vaccines—Novavax or Pfizer's mRNA vaccine—better protects adults from getting sick with COVID-19. It also compared protection in people who got a booster to those who did not. Over 1,100 adults in Utah participated, completing weekly surveys and home tests for about five months to track infections and symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Utah School of Medicine
Salt Lake City, Utah, 84108, United States
Conditions
Explore the condition pages connected to this study.